An Efficacy and Safety Study of Basimglurant (NOE-101) in Patients With Trigeminal Neuralgia.
Clinical trial NCT05217628 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05217628
- Sponsor
- Noema Pharma AG
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2027-02-02
- Enrollment
- 166
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.